Counteract sedentary habits by incorporating at least 150 minutes of moderate exercise per week, such as walking, cycling, ...

According to the National Kidney Foundation, 123,000 Americans are on that waitlist. More than a 100,000 of those waiting ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Fact checked by Jillian Dara The Food and Drug Administration (FDA) on Tuesday approved Ozempic (semaglutide) to reduce the ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

HNN Investigates has learned each year up to nearly half of the kidneys donated in the islands wind up going to patients ...

The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...